by Robin Dvorak | May 15, 2025
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead program is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of MASH,...
by Robin Dvorak | May 8, 2025
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of inflammatory disease, to revolutionize outcomes for patients. Sonelokimab inhibits IL-17A and...
by Robin Dvorak | Jan 30, 2025
Marathon Health, a leading provider of direct primary care for employers and unions in the U.S., is transforming healthcare delivery through a patient-first approach, providing more convenient access to in-person and virtual care, leading to better health outcomes for...
